Summary
Certain types of the human papilloma virus (HPV) are well established as the primary cause of cervical cancer. Several studies have shown that HPV testing can improve the detection rate of high-grade cervical intraepithelial neoplasia (CIN), but these have been carried out primarily in younger women. In this study we evaluated the role of HPV testing as an adjunct to cytology in women aged 35 or over. An additional aim was to evaluate commercially available kits for HPV testing. A total of 2988 eligible women aged 34 or more attending for a routine smear in 40 general practitioner practices received HPV testing in addition to routine cytology, after having given written informed consent. Samples were assayed by polymerase chain reaction (PCR) and two versions of the Hybrid Capture test for HPV, and women were invited for colposcopy if there was any cytological abnormality (including borderline smears) or the PCR test was positive. Any apparent abnormality was biopsied and loop-excision was performed as necessary. CIN was judged by histology; 42 women had high-grade CIN, of which six were cytology negative (86% sensitivity for borderline or worse) and three had a borderline smear (79% sensitivity for mild dyskaryosis or worse). The positive predictive value of a borderline smear was only 3.1%. Eleven high-grade lesions were negative by the PCR HPV test (sensitivity 74%). The first generation Hybrid Capture II test had a similar sensitivity but an unacceptably high false positive rate (18.3%), while the newer Hybrid Capture II microtitre kit had a 95% sensitivity and a 2.3% positivity rate in normal women when used at a 2 pg ml–1 cut-off (positive predictive value 27%). Cytology performed very well in this older cohort of women. The newer Hybrid Capture II microtitre test may be a useful adjunct, especially if the results reported here are reproducible in other studies. A combined screening test offers the possibility of greater protection and/or longer screening intervals, which could reduce the overall cost of the screening programme.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Cox, JT, Lorincz, AT, Schiffman, MH, Sherman, ME, Cullen, A & Kurman, RJ (1995). Human papillomavirus testing by hybrid capture is useful in triaging women with a cytologic diagnosis of ASCUS. Am J Obstet Gynecol 172: 946.
Cuzick, J & Sasieni, P (1997). Estimates of the cost impact of introducing HPV testing into a cervical screening programme. In: New Developments in Cervical Cancer Screening and Prevention, Franco Monsonego, Blackwell Science Ltd: Oxford, 364–72.
Cuzick, J, Terry, G, Ho, L, Hollingworth, T & Anderson, M (1994). Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 69: 167–171.
Cuzick, J, Szarewski, A, Terry, G, Ho, L, Hanby, A, Maddox, P, Anderson, M, Kocjan, G, Steele, ST & Guillebaud, J (1995). Human papillomavirus testing in primary cervical screening. Lancet 345: 1533–1537.
Ferenczy, A, Franco, E, Arseneau, J, Wright, TC & Richart, RM (1996). Diagnostic performance of Hybrid Capture HPV DNA assay combined with liquid-based cytology. Am J Obstet Gynecol 175: 651.
Hatch, KD, Schneider, A & Abdel-Nour, MW (1995). An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy. Am J Obstet Gynecol 172: 1150.
Hildesheim, A, Schiffman, MH, Gravitt, PE, Glass, AG, Greer, CE, Zhang, T, Scott, DR, Rush, BB, Lawler, P, Sherman, ME, Kurman, RJ & Manos, MM (1994). Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169: 235–240.
Hirschowitz, L, Raffle, AE, Mackenzie, EF & Hughes, AO (1992). Long term follow up of women with borderline cervical smear test results: effects of age and viral infection on progression to high grade dyskaryosis. BMJ 304: 1209–1212.
Ho, GYF, Burk, RD, Klein, S, Kadish, AS, Chang, CJ, Palan, P, Basu, J, Tachezy, R, Lewis, R & Romney, S (1995). Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87: 1365–1371.
Huang, S, Afonina, I, Miller, BA & Beckmann, AM (1997). Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 70: 408–411.
Jones, MH, Jenkins, D, Cuzick, J, Wolfendale, MR, Jones, JJ, Balogun-Lynch, C, Usherwood, M, McD & Singer, A (1992). Mild cervical dyskaryosis: safety of cytological surveillance. Lancet 339: 1440–1443.
Kinney, WK, Manos, MM, Hurley, LB & Ransley, JE (1998). Where’s the high grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 91: 973–976.
Londesborough, P, Ho, L, Terry, G, Cuzick, J, Wheeler, C & Singer, A (1996). Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69: 364–368.
Soutter, WP, Wisdom, S, Brough, AK & Monaghan, JM (1986). Should patients with mild atypia in a cervical smear be referred for colposcopy?. Br J Obstet Gynaecol 93: 70–74.
Terry, G, Ho, L, Szarewski, A & Cuzick, J (1994). Semiautomated detection of human papillomavirus DNA of high and low oncogenic potential in cervical smears. Clin Chem 40: 1890–1892.
Walboomers, JMM, de Roda Husman, AM, Snijders, PJF, Stel, HV, Risse, EKJ, Helmerhorst, TJM, Voohorst, FJ & Meijer, CJLM (1995). Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol 48: 728–732.
Walker, EM, Dodgson, J & Duncan, ID (1986). Does mild atypia on a cervical smear warrant further investigation?. Lancet ii: 672–673.
Author information
Authors and Affiliations
Additional information
Correspondence to: J Cuzick
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Cuzick, J., Beverley, E., Ho, L. et al. HPV testing in primary screening of older women. Br J Cancer 81, 554–558 (1999). https://doi.org/10.1038/sj.bjc.6690730
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690730
Keywords
This article is cited by
-
Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology
European Journal of Clinical Microbiology & Infectious Diseases (2012)
-
Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women
BMC Infectious Diseases (2010)
-
Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women
BMC Cancer (2010)
-
Impfungen gegen humanes Papillomvirus bei Jugendlichen
Monatsschrift Kinderheilkunde (2007)
-
Impfungen gegen humanes Papillomvirus bei Jugendlichen
Monatsschrift Kinderheilkunde (2005)